Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers:The Prospective Nordic Study NMDSG14B

MLA

Daniel Olsson, et al. Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers:The Prospective Nordic Study NMDSG14B. Nov. 2020. EBSCOhost, https://doi.org/10.1182/blood-2020-138782.

APA

Daniel Olsson, Sten Eirik W. Jacobsen, Kirsten Groenbaek, Soili Kytölä, Duruta Weber, Magnus Tobiasson, Jörg Cammenga, Lone Smidstrup Friis, Tatjana Pandzic, Lennart Nilsson, Ingunn Dybedal, Johanna Illman, Simone Weström, Lucia Cavelier, Eva Hellstrom Lindberg, Olle Werlenius, Fryderyk Lorentz, Astrid Olsnes Kittang, Freja Ebeling, … Marios Dimitriou. (2020). Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers:The Prospective Nordic Study NMDSG14B. https://doi.org/10.1182/blood-2020-138782

Chicago

Daniel Olsson, Sten Eirik W. Jacobsen, Kirsten Groenbaek, Soili Kytölä, Duruta Weber, Magnus Tobiasson, Jörg Cammenga, et al. 2020. “Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers:The Prospective Nordic Study NMDSG14B,” November. doi:10.1182/blood-2020-138782.